Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance. (Q46495913)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

K-H Shin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

M H Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

K S Lim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

K-S Yu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

I-J Jang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

19 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

601-609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784264%20AND%20SRC:MED&resulttype=core&format=json

Substrates of human hepatic cytochrome P450 3A4.

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Noninvasive tests of CYP3A enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Genetic contribution to variable human CYP3A-mediated metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

The CYP3A4*18 genotype in the cytochrome P450 3A4 gene, a rapid metabolizer of sex steroids, is associated with low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Late stent thrombosis in drug-eluting stents: return of the 'VB syndrome'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Metabolism of 4 beta -hydroxycholesterol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Urinary 6?-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Venous hemangioma of parapharyngeal space with calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

The role of cytochrome P450 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the delta 5 and delta 4 pathways of steroidogenesis in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Developmental expression of the major human hepatic CYP3A enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Heat-map visualization of gas chromatography-mass spectrometry based quantitative signatures on steroid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Evaluation of plasma enzyme activities using gas chromatography-mass spectrometry based steroid signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Effect of age and gender on tirilazad pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

Unexpected formation of hydroxybiphenylmethane derivatives and some new observations on Labat test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128

inferred from DOI database lookup

7 January 2021

based on heuristic

4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.128